4//SEC Filing
Shah Vinay 4
Accession 0001213900-23-050514
CIK 0001708331other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:18 PM ET
Size
5.5 KB
Accession
0001213900-23-050514
Insider Transaction Report
Form 4
Shah Vinay
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-06-20+100,000→ 100,000 totalExercise: $0.99From: 2024-06-20Exp: 2033-06-20→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest after 12 months of continuous service, and the remaining 75% of the shares subject to the Option will vest in equal monthly installments over the next 36 months of continuous service
Documents
Issuer
Virpax Pharmaceuticals, Inc.
CIK 0001708331
Entity typeother
Related Parties
1- filerCIK 0001753078
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:18 PM ET
- Size
- 5.5 KB